Literature DB >> 15659556

High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection.

Robert Belshaw, Aris Katzourakis, Jan Paces, Austin Burt, Michael Tristem.   

Abstract

There are at least 31 families of human endogenous retroviruses (HERVs), each derived from an independent infection by an exogenous virus. Using evidence of purifying selection on HERV genes, we have shown previously that reinfection by replication-competent elements was the predominant mechanism of copying in some families. Here we analyze the evolution of 17 HERV families using d(N)/d(S) ratios and find a positive relationship between copy number and the use of additional copying mechanisms. All families with more than 200 elements have also used one or more of the following mechanisms: (1) complementation in trans (elements copied by other elements of the same family; HERV-H and ERV-9), (2) retrotransposition in cis (elements copying themselves) within germ-line cells (HERV-K(HML3)), and (3) being copied by non-HERV machinery (HERV-W). We discuss why these other mechanisms are rare in most families and suggest why complementation in trans is significant only in the larger families.

Entities:  

Mesh:

Year:  2005        PMID: 15659556     DOI: 10.1093/molbev/msi088

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  67 in total

1.  Human endogenous retroviral elements as indicators of ectopic recombination events in the primate genome.

Authors:  Jennifer F Hughes; John M Coffin
Journal:  Genetics       Date:  2005-09-12       Impact factor: 4.562

2.  Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis.

Authors:  Renée Douville; Jiankai Liu; Jeffrey Rothstein; Avindra Nath
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

Review 3.  Transposable elements as drivers of genomic and biological diversity in vertebrates.

Authors:  Astrid Böhne; Frédéric Brunet; Delphine Galiana-Arnoux; Christina Schultheis; Jean-Nicolas Volff
Journal:  Chromosome Res       Date:  2008       Impact factor: 5.239

4.  Coevolution of retroelements and tandem zinc finger genes.

Authors:  James H Thomas; Sean Schneider
Journal:  Genome Res       Date:  2011-07-22       Impact factor: 9.043

Review 5.  Border collies of the genome: domestication of an autonomous retrovirus-like transposon.

Authors:  M Joan Curcio
Journal:  Curr Genet       Date:  2018-06-21       Impact factor: 3.886

6.  Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome.

Authors:  Stephen D Barr; Jeremy Leipzig; Paul Shinn; Joe R Ecker; Frederic D Bushman
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences.

Authors:  Rafael Contreras-Galindo; Mark H Kaplan; Derek Dube; Marta J Gonzalez-Hernandez; Susana Chan; Fan Meng; Manhong Dai; Gilbert S Omenn; Scott D Gitlin; David M Markovitz
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

8.  AIDS alters the commensal plasma virome.

Authors:  Linlin Li; Xutao Deng; Piyada Linsuwanon; David Bangsberg; Mwebesa Bosco Bwana; Peter Hunt; Jeffrey N Martin; Steven G Deeks; Eric Delwart
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

9.  Gorillas have been infected with the HERV-K (HML-2) endogenous retrovirus much more recently than humans and chimpanzees.

Authors:  Joseph R Holloway; Zachary H Williams; Michael M Freeman; Uriel Bulow; John M Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-04       Impact factor: 11.205

10.  Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences.

Authors:  Georg Laufer; Jens Mayer; Benedikt F Mueller; Nikolaus Mueller-Lantzsch; Klemens Ruprecht
Journal:  Retrovirology       Date:  2009-04-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.